Alchemy

Big news! 🎉 We’re thrilled to announce that Alchemy has raised a $31M Seed round, led by Andreessen Horowitz with participation from Magic Johnson Enterprises, Sheryl Sandberg, Banc of California and existing investors Twine Ventures, Springbank and AlleyCorp. Alchemy builds and operates in-house pharmacies for safety net clinics, with a focus on patients living with HIV and Hepatitis C. We provide the entire physical, clinical, and digital infrastructure needed to operate and grow best-in-class pharmacy programs. Last week, Alchemy Founder and Co-CEO Sid Viswanathan sat down with Earvin “Magic” Johnson to discuss his personal journey with HIV, his vision for advancing HIV access and equity in the U.S., and the role he believes Alchemy will play in the coming decades. Full press release: https://lnkd.in/gnk3Jpkt #Fundraise #Alchemy #Pharmacy

At Alchemy, Peter Park and I have been in touch with Secretary Kennedy’s team at U.S. Department of Health and Human Services (HHS) regarding the recent news headlines around funding cuts to HIV prevention and structural changes to Centers for Disease Control and Prevention’s division for HIV prevention. The key message and area we wanted to focus on was the critical link between HIV prevention and the CDC’s Section 318 Grants. These are the grants that every STD clinic in the country uses in order to qualify for the 340B drug program Our message to Secretary Kennedy’s team was simple =>  𝗪𝗲 𝗺𝘂𝘀𝘁 𝗺𝗮𝗶𝗻𝘁𝗮𝗶𝗻 𝗦𝗲𝗰𝘁𝗶𝗼𝗻 318 𝗴𝗿𝗮𝗻𝘁𝘀 𝘁𝗼 𝗽𝗿𝗲𝘃𝗲𝗻𝘁 𝘁𝗵𝗲 𝘀𝗽𝗿𝗲𝗮𝗱 𝗼𝗳 𝗛𝗜𝗩 𝗶𝗻 𝗼𝘂𝗿 𝗰𝗼𝘂𝗻𝘁𝗿𝘆, and we highlighted two main reasons. 1. 𝗛𝗜𝗩 𝗽𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗦𝗲𝗰𝘁𝗶𝗼𝗻 318 𝗶𝗺𝗽𝗮𝗰𝘁𝘀 𝗮𝗹𝗹 𝗔𝗺𝗲𝗿𝗶𝗰𝗮𝗻𝘀. The CDC’s Section 318 grants support STD clinics that serve ALL parts of the American population, specifically impacting white, straight, male, rural HIV patients in our country.  2. HIV prevention grants (or more broadly, STD grants) are 𝗳𝗼𝗿𝗰𝗲 𝗺𝘂𝗹𝘁𝗶𝗽𝗹𝗶𝗲𝗿𝘀 𝗳𝗿𝗼𝗺 𝗮𝗻 𝗲𝗳𝗳𝗶𝗰𝗶𝗲𝗻𝗰𝘆 𝗼𝗳 𝗳𝘂𝗻𝗱𝘀 𝗽𝗲𝗿𝘀𝗽𝗲𝗰𝘁𝗶𝘃𝗲. Every dollar conferred through grant funding force multiplies 3:1 (or even greater) through 340B program savings. Since Section 318 grants allow clinics to participate in the 340B drug program, and at its core, the 340B program is funded by pharmaceutical manufacturers through discounts vs. direct taxpayer dollars, every dollar of Section 318 grants is essentially “matched and multiplied" by manufacturers through 340B program discounts. Link to full blog post here => https://lnkd.in/dRASZ5wZ #HIVPrevention #Section318 #CDC #340B

Our Founders Peter Park and Sid Viswanathan have been in touch with Secretary Kennedy’s team at U.S. Department of Health and Human Services (HHS) regarding the recent news headlines around funding cuts to HIV prevention and structural changes to Centers for Disease Control and Prevention’s division for HIV prevention. The key message and area we wanted to focus on was the critical link between HIV prevention and the CDC’s Section 318 Grants. These are the grants that every STD clinic in the country uses in order to qualify for the 340B drug program. Our message to Secretary Kennedy’s team was simple =>  𝗪𝗲 𝗺𝘂𝘀𝘁 𝗺𝗮𝗶𝗻𝘁𝗮𝗶𝗻 𝘁𝗵𝗲 𝗦𝗲𝗰𝘁𝗶𝗼𝗻 318 𝗴𝗿𝗮𝗻𝘁𝘀 𝘁𝗼 𝗽𝗿𝗲𝘃𝗲𝗻𝘁 𝘁𝗵𝗲 𝘀𝗽𝗿𝗲𝗮𝗱 𝗼𝗳 𝗛𝗜𝗩 𝗶𝗻 𝗼𝘂𝗿 𝗰𝗼𝘂𝗻𝘁𝗿𝘆, and we highlighted two main reasons. 1. HIV prevention and Section 318 impacts all Americans. The CDC’s Section 318 grants support STD clinics that serve ALL parts of the American population, specifically impacting white, straight, male, rural patients in our country.  2. HIV prevention grants (or more broadly, STD grants) are force multipliers from an efficiency of funds perspective. For every dollar conferred through grant funding force multiplies 3:1 (or even greater) through 340B program savings. Since Section 318 grants allow clinics to participate in the 340B drug program, and at its core, the 340B program is funded by pharmaceutical manufacturers through discounts vs. direct taxpayer dollars, every dollar of Section 318 grants is essentially “matched and multiplied" by manufacturers through 340B program discounts. Link to full blog post here => https://lnkd.in/d_7bt6Wb #HIVPrevention #Section318 #CDC #340B

We’re excited to welcome Kyle Folk, PharmD, AAHIVP as Alchemy’s Director of Pharmacy Operations! Kyle brings 14 years of pharmacy experience, with deep expertise in HIV care and 340B program management. Most recently, he served as Associate Director of Community Pharmacy at Genoa Healthcare, where he led teams specializing in HIV, Hepatitis B and C, fertility, and more. He also developed Nevada's first pharmacy-led PrEP collaborative practice agreement, driving a 200% increase in PrEP dispensing. “HIV care has always been my passion,” Kyle shared. “Alchemy’s integrated pharmacy model — connecting patients, providers, and pharmacies — creates better patient outcomes.” ➡️ Learn more about Kyle: https://lnkd.in/gsxAenw8

🎉  We are live in San Antonio! We’re thrilled to announce the opening of our latest in-house pharmacy in partnership with BEAT AIDS! As we mark the launch, we sat down with long-time Executive Director, Michele Durham, to learn more about the organization's origin and mission, her vision for the in-house pharmacy, and her experience working with Alchemy. "Having the pharmacy in-house makes such a difference for our patients. The convenience, the trust, and the ability to provide wraparound care all in one place — it’s a game-changer for the community we serve," shared Michele Durham. 🔗 Full conversation on our blog: https://lnkd.in/gGdi2vj6

We're #hiring a Director of Sales to advance Alchemy's mission! Alchemy builds and operates in-house pharmacies for safety net clinics, with a focus on STD clinics, Ryan Whites and FQHCs serving patients living with #HIV and #HepatitisC. Passionate about improving healthcare access? Have experience partnering with #340B covered entities? We'd love to hear from you. https://lnkd.in/g-vxRgCS

In February, 340B news centered on developments across all three branches of government. Here are the month’s top stories: 🏥 Senate confirms RFK Jr. as HHS Secretary, putting him in charge of healthcare programs including 340B ⚖️ LGBTQ nonprofits and HIV service organizations sue Trump over anti-trans executive orders 📜 State-level action accelerates with 17 states introducing bills to protect 340B contract pharmacy access so far this year 🏛️ Congressional action on 340B appears unlikely in the near term, though key bills may advance later this year, according to industry experts Want more updates like this? Sign up for our newsletter: https://lnkd.in/gE-NhBpV Links to these articles in the comments.

Today we are featuring Claudia Callinan, Pharmacist in Charge at Community Care Resources of Florida, as our Pharmacist of the Month! 🌟 Claudia embodies Alchemy's values with a deep commitment to serving her patients. Please join us in celebrating Claudia's outstanding contributions! #Pharmacy #PharmacistoftheMonth #HealthcareHeros

📈 Want to boost your pharmacy's prescription capacity without hiring more staff? Today on our blog, Alchemy's Andy Storjohann, PharmD and Brian Franks share the 5 workflow principles they deployed to help one pharmacy 𝗱𝗼𝘂𝗯𝗹𝗲 𝗶𝘁𝘀 𝗱𝗮𝗶𝗹𝘆 𝘃𝗼𝗹𝘂𝗺𝗲 at no additional cost. 🔗 Full case study: https://lnkd.in/gqCaBCHs

Alchemy is thrilled to be partnered with Banc of California! Through this partnership we’re supporting our clinic partners with the financing they need to build and launch in-house pharmacies—without the burden of a large upfront cash outlay. This debt financing fuels growth and allows clinics to focus their time and resources on what matters most: exceptional patient care.